Phibro Animal Health (PAHC) Tops Q2 EPS by 11c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Phibro Animal Health Corp. (PAHC) PT Raised to $22 at Barclays
February 7, 2025 2:18 PM ESTBarclays analyst Balaji Prasad raised the price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $22.00 (from $20.00) while maintaining a Underweight rating.
The analyst comments "2QFY25 Rev / Adj. EPS beat cons by ~2%/~25%. Growth was led by AH (+11% excl. new MFA; +33%... More



